RecruitingPhase 4NCT06883123

Efficacy of Simbrinza and Rocklatan vs Cosopt and Latanoprost

Efficacy and Tolerability of Simbrinza and Rocklatan vs. Cosopt


Sponsor

Prairie Eye Center

Enrollment

70 participants

Start Date

May 14, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

A randomized, multi-site, parallel-group, prospective study of patients who are adults with a diagnosis of mild to moderate open-angle glaucoma (OAG), currently on an on-label use of combination topical medication of Cosopt and Latanoprost for a minimum of 1 month.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing two different combinations of eye drop medications to see which is more effective at lowering eye pressure in adults with mild to moderate open-angle glaucoma. One combination is Simbrinza + Rocklatan, and the other is Cosopt + Latanoprost. **You may be eligible if...** - You are 18 or older - You have been diagnosed with mild to moderate open-angle glaucoma - You are currently using both Cosopt and Latanoprost eye drops together for at least 1 month - Your eye pressure falls within a specific range at baseline - Your corneal thickness is within a normal range **You may NOT be eligible if...** - You have had eye surgery or laser treatment in the past year (except certain laser treatments more than a year ago) - You have known allergies to any of the study medications - You have uncontrolled systemic health conditions - You have significant corneal disease or other major eye problems - You are pregnant, breastfeeding, or planning a pregnancy Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGSimbrinza 0.2%-1% Ophthalmic Suspension

brinzolamide and brimonidine tartrate

DRUGRocklatan 0.02%-0.005% Ophthalmic Solution

netarsudil and latanoprost

DRUGCosopt PF 2%-0.5% Ophthalmic Solution

dorzolamide hydrochloride and timolol maleate

DRUGLatanoprost 0.005% Ophthalmic Solution

Latanoprost


Locations(1)

Prairie Eye Center

Springfield, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06883123


Related Trials